Logo
S

SIGA Technologies

95 employees

SIGA is a leader in global health, developing medicines to prevent and treat emerging infectious diseases with high unmet medical needs. Infectious diseases pose an imminent and severe threat to global health that cannot be adequately addressed with vaccines alone. Smallpox, mpox, and other orthopoxviruses are particularly worrisome because they are highly infectious and deadly. We are developing best-in-class products to treat these infections in patients worldwide.

Investor insights

Funding rounds participated in

$23M sweet spot round size

Investor type

Public Company

Basic info

Industry

Biotechnology

Sectors

Biotechnology

Date founded

1995

Funding rounds raised

Total raised

$23M

from 1 investors over 1 rounds

S

SIGA Technologies raised $23M on July 17, 2020

Investors: U.S. Department of Defense

FAQ